DeepMed Research

INSTITUT CLAUDIUS REGAUD

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.claudiusregaud.fr

Clinical Trials

Effect on Xpert® Bladder Test of Urines Inflammatory Milieu Induced by BCG Treatment of Patients With NMIBC

Not Applicable

Conditions: Non Muscle Invasive Bladder Cancer
Treatment by BCG

Interventions: Biological: Xpert bladder Test

First Posted Date: 2016-09-09

Last Posted Date: 2016-09-09

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 24

Registration Number: NCT02895620

Locations: 🇫🇷
Institut claudius regaud IUCT ONCOPOLE, Toulouse, France

Prospective and Retrospective Breast Cancer Database

Recruiting

Conditions: Breast Cancer

First Posted Date: 2016-08-31

Last Posted Date: 2016-08-31

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 10000

Registration Number: NCT02884284

Locations: 🇫🇷
Institut claudius regaud IUCT ONCOPOLE, Toulouse, France

Prospective Melanoma Database

Recruiting

Conditions: Melanoma

First Posted Date: 2016-08-31

Last Posted Date: 2016-08-31

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 10000

Registration Number: NCT02884362

Locations: 🇫🇷
Institut claudius regaud IUCT ONCOPOLE, Toulouse, France

Study of Trans-tissular Migration of Macrophages Associated to Human Breast Cancer

Not Applicable

Conditions: Breast Cancer

Interventions: Other: Define macrophages migration mode

First Posted Date: 2016-08-23

Last Posted Date: 2016-09-13

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 200

Registration Number: NCT02876497

Study of SXL01 in Patients With Metastatic Castration-Resistant Prostate Cancer (PROSTIRNA)

Phase 1

Withdrawn

Conditions: Prostatic Cancer, Castration-Resistant

Interventions: Drug: SXL01

First Posted Date: 2016-08-15

Last Posted Date: 2021-01-20

Lead Sponsor: Institut Claudius Regaud

Registration Number: NCT02866916

Locations: 🇫🇷
Institut Claudius Regaud, Toulouse, France

A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma

Phase 1

Completed

Conditions: Glioblastoma

Interventions: Radiation: Hypofractionated stereotactic radiation therapy
Drug: Durvalumab

First Posted Date: 2016-08-15

Last Posted Date: 2024-12-04

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 108

Registration Number: NCT02866747

Locations: 🇫🇷
Hopital Avicenne, Bobigny, France
🇫🇷
Institut de Cancerologie de L'Ouest, Angers, France
🇫🇷
Centre Georges Francois Leclerc, Dijon, France

and more 7 locations

From the Characterization of the Cholesterol-epoxide Pathway Deregulation to New Therapeutic Perspectives in Breast Cancers

Not Applicable

Conditions: Breast Cancer

Interventions: Other: cohort of BC of each subtypes

First Posted Date: 2016-08-11

Last Posted Date: 2016-08-11

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 350

Registration Number: NCT02863900

Locations: 🇫🇷
Institut Claudius Regaud, Toulouse, France

Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO)

Not Applicable

Completed

Conditions: METASTATIC CANCER

Interventions: Other: current standard of care
Other: CREDO standard of care

First Posted Date: 2016-08-05

Last Posted Date: 2022-09-29

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 667

Registration Number: NCT02857400

Locations: 🇫🇷
Centre Hospitalier Auch, Auch, France
🇫🇷
Hopital Rangueil, Toulouse, France
🇫🇷
Institut Claudius Regaud, Toulouse, France

Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin

Not Applicable

Completed

Conditions: Medullary Thyroid Cancer

Interventions: Other: 18F-DOPA

First Posted Date: 2016-08-04

Last Posted Date: 2021-03-08

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 24

Registration Number: NCT02856347

Locations: 🇫🇷
CHU Haut-Lévêque, Bordeaux, France
🇫🇷
CHU Limoges, Limoges, France
🇫🇷
CHU Timone, Marseille, France

and more 2 locations

Cost Utility of Radical Surgery in Ovarian Cancer

Not Applicable

Completed

Conditions: Ovarian Cancer

Interventions: Other: Collection of additional data with questionnaires

First Posted Date: 2016-08-03

Last Posted Date: 2025-04-24

Lead Sponsor: Institut Claudius Regaud

Target Recruit Count: 200

Registration Number: NCT02854215

Locations: 🇫🇷
Institut Bergonie, Bordeaux, France
🇫🇷
Centre Jean Perrin, Clermont Ferrand, France
🇫🇷
Chu Clermont Ferrand, Clermont Ferrand, France

and more 7 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy